OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) Net Cash Flow Growth (3y) (2025 - 2026)

OSR Health (OSRHW) Net Cash Flow Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn -8.34%
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 36.60%
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn -
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn -35.85%
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 106.37%
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn 67.39%
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn -70.95%
8 Royalty Pharma 27.29 Bn 26.45 Bn - 4.55%
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn 52.78%
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 53.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -30.35%
Dec 31, 2025 -113.70%
Sep 30, 2025 405.20%
Jun 30, 2025 -59.65%